Ash Stevens certified green and safe

By Phil Taylor

- Last updated on GMT

Related tags Chemical industry

Active pharmaceutical ingredient (API) manufacturer Ash Stevens Inc has been accredited under an industry-backed scheme that certifies companies whose processes are environmentally sound and safe.

The ChemStewards programme, operated by the Synthetic Organic Chemical Manufacturers Association (SOCMA) in the US, is awarded to companies which can demonstrate that they comply with federal laws and regulations covering environmental, health, safety and security.

ChemStewards was created from industry's commitment to reducing the environmental footprint left by member's facilities,​” said ASI in a statement. The scheme assesses a company’s activities in areas such as chemical process safety (e.g. thermal hazard analysis), exposure assessment and mitigation programmes, operator safety and waste management.

The accreditation “dovetails very nicely with the recent addition of a process safety laboratory here at Ash Stevens​," said Dr Stephen Munk, president and CEO at the company. It has invested more than $15m in its 30,000 sq. ft. manufacturing facility - located in Riverview, Michigan, over the past five years.

The ChemStewards programme has been in operation since 2005, and SOCMA said recently that more than 80 per cent of its member companies had undergone an on-site audit, the final step before certification, by the end of 2008.

SOCMA is the US-based trade association of batch and custom manufacturers, which includes contract manufacturers of pharmaceutical intermediates and APIs. ChemStewards certification is a requirement of joining the group.

SOCMA claims ChemStewards is the only certification system designed specifically for companies operating in the batch, custom and specialty chemicals industry.

Related news

Related products

A Guide Through the API Drug Development Pipeline.

A Guide Through the API Drug Development Pipeline.

Content provided by Lonza Small Molecules | 04-Apr-2023 | Insight Guide

With the complexities associated with API and HPAPI drug development, it’s necessary to lean on the experts. With Q&A sections, insights and articles...

The Complete Guide to eRegulatory and eSource

The Complete Guide to eRegulatory and eSource

Content provided by Florence Healthcare | 01-Apr-2023 | Insight Guide

Shifting to eRegulatory and eSource workflows is a requirement for clinical trial sites to continue to scale and grow their studies. This guide is designed...

Related suppliers

Follow us


View more